NL-OMON23868招募中不适用
CLINICAL, PARASITOLOGICAL AND PHARMACO-ECONOMICAL EVALUATION OF A 3 DAYS VERSUS 7 DAYS PENTAMIDINE ISETHIONATE REGIMEN FOR CUTANEOUS LEISHMANIASIS IN SURINAME.
Koninklijk Instituut voor de Tropen (KIT)0 个研究点目标入组 220 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient is 16 years and older of age;
- •2. Histopathology and/or smear of skin biopsy confirms diagnosis CL;
排除标准
- •1. Patients with CL treated in the past 6 months;
- •2. Pregnancy or lactation;
研究者
相似试验
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings - PRO.WIpatients with severe inherited VWD unresponsive to DDAVP and with frequent bleedingsMedDRA version: 8.1Level: PTClassification code 10047715Term: Von Willebrand's diseaseEUCTR2006-001383-23-ITFONDAZIONE CENTRO EMOFILIA E TROMBOSI ANGELO BIANCHI BONOMI24
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1 Level: PT Classification code 10047715 Term: Von Willebrand's disease System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2006-001383-23-GBProf Flora Peyvandi, MD24
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment ofsecondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWDand frequent bleedingsPatients with severe, inherited Von Willebrand’s disease and frequent bleedingsMedDRA version: 16.0Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2006-001383-23-DEFondazione IRCCS Cà Granda Ospedale Maggiore Policlinico24
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2006-001383-23-ESFondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico24
已完成
不适用
PROPHET: Prospective clinical and pharmacoeconomic outcomes study of different first-line antiretroviral treatment strategiesB24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00006321DAGNÄ e.V. (Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung HIV-Infizierter e.V.) vertreten durch Dr. med. Knud Schewe und Dr. med. Stefan Klauke444